Dyne Therapeutics wins FDA Priority Review for DMD drug z-rostudirsen, with key catalysts and pipeline upside. Click for more ...

MycoTechnology is pairing its honey truffle sweet protein with Adorvia Biotechnology's Reb M stevia to offer companies a new ...

A new year brings a fresh Fierce Biotech Fundraising Tracker designed to record the significant amount of venture capital that flows into biopharma. We’re keeping the same guidelines used for last ...

Vanda Pharma cash could be depleted by the end of 2027; multiple pipeline bets heighten both risk and opportunity. Read my ...

Nuvation Bio Inc. (NYSE:NUVB) is one of the best small cap stocks to buy with the highest upside potential. RBC Capital ...

CBI told a special court that a Latur coaching owner paid Rs 5 lakh to obtain leaked NEET-UG 2026 chemistry questions.

Indian companies are proving multiple routes to global relevance: developing novel science in India first and taking it ...

The ATAI deal is a clear signal Lilly will fund and scale psychedelic mental-health assets, not just dabble. LLY’s cash ...

The AI-Driven Research Intelligence Platform Set to Revolutionize Biomanufacturing and Market Viability Mapping.

The Phase 2 data exceeded expectations, lifting company shares as high as nearly $130 apiece and building the case for what ...

Moderna (MRNA) closed the most recent trading day at $66.98, moving -1.89% from the previous trading session. This change lagged the S&P 500's daily loss of 0.79%. On the other hand, the Dow ...